643
Participants
Start Date
September 30, 2006
Primary Completion Date
December 31, 2007
Study Completion Date
September 30, 2009
Golimumab
2mg/kg or 4mg/kg will be administered as an IV infusion over 30 minutes
Methotrexate
Active MTX capsules, filled with microcrystalline cellulose (Avicel PH 102) and a 2.5 mg MTX tablet, will be administered at the same dose as before the study entry.
Placebo
Placebo solution will be administered through IV infusion in Group V and oral placebo capsules (sham MTX) filled with microcrystalline cellulose (Avicel PH 102) will be administered in Group II and IV.
Peoria
Aventura
Orlando
Tampa
Atlanta
Lincoln
Omaha
Voorhees Township
Albany
Roslyn
Charlotte
Oklahoma City
Duncansville
Norristown
West Reading
Willow Grove
Amarillo
Fort Worth
Lubbock
Spokane
Buenos Aires
Córdoba
Rosario
San Juan
San Miguel de Tucumán
Santa Fe
Fitzroy
Heidelberg
Maroochydore
Melbourne
Perth
Woodville
Barranquilla
Bogotá
Bucaramanga
Floridablanca
Erlangen
Hamburg
Magdeburg
München
Budapest
Szolnok
Daugavpils
Riga
Kaunas
Klaipėda
Šiauliai
Vilnius
Ipoh
Kuching
Precinct 7
Selangor Darul Ehasan
Msd06 Gwardiamangia
Colonia del Valle
Guadalajara
Guadalajara Jalisco
Monterrey
Christchurch
Dunedin
Rotorua
Takapuna Auckland
Timaru
Lima
Bialystok
Elblag
Krakow
Warsaw
Włoszczowa
Kiev
Kyiv
Symferpol
Zhaporizhzhya
Lead Sponsor
Collaborators (1)
Schering-Plough
INDUSTRY
Centocor, Inc.
INDUSTRY